| t | BF10 | Z | Cohenâs d | 95% CI for Cohenâs d | CELLS | CTRL | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | M | SD | SE | M | SD | SE | |||||
Tissue morphology | 2.97** | 4.04 | ââ2.134* | 0.99 | 0.16 | 1.78 | 69.56 | 19.11 | 6.37 | 57.78 | 9.98 | 3.33 |
Cell morphology | 2.23 | 2.23 | ââ1.96 | 0.74 | ââ0.02 | 1.47 | 69.56 | 22.82 | 7.61 | 51.11 | 18.82 | 6.27 |
Chondrocytes clustering | ââ1.00 | ââ1.00 | ââ0.91 | ââ033 | ââ1.00 | 0.35 | 69.11 | 16.50 | 5.50 | 58.67 | 19.25 | 6.42 |
Surface architecture | 2.11 | 2.11 | ââ1.72 | 0.70 | ââ0.05 | 1.42 | 53.89 | 5.40 | 1.80 | 56.22 | 8.18 | 2.73 |
Basal integration | 3.63** | 3.64 | ââ2.55* | 1.21 | 0.32 | 2.07 | 88.11 | 5.82 | 1.94 | 75.56 | 18.78 | 6.26 |
Formation of tidemark | 6.29*** | 6.29 | ââ2.67*** | 2.10 | 0.88 | 3.28 | 89.11 | 5.37 | 1.79 | 82.44 | 6.15 | 2.05 |
Subchondral bone abnormalities | 3.15* | 3.15 | ââ2.43** | 1.05 | 0.21 | 1.86 | 36.78 | 8.09 | 2.70 | 24.67 | 5.43 | 1.81 |
Inflammation | 1.33 | 1,33 | ââ1.15 | 0.44 | ââ0.26 | 1.12 | 88.67 | 10.89 | 3.63 | 70.67 | 17.82 | 5.94 |
Abnormal calcification/ossification | 1.00 | â | ââ1.00 | â | â | â | 92.56 | 8.95 | 2.98 | 88.67 | 14.01 | 4.67 |
Vascularisation | 2.28 | 2.28 | ââ2.08* | 0.76 | ââ0.01 | 1.49 | 100.00 | 0.00 | 0.00 | 98.56 | 4.33 | 1.44 |
Surface/superficial assessment | 1.80 | 1.80 | ââ1.48 | 0.60 | ââ0.13 | 1.30 | 78.33 | 21.71 | 7.24 | 58.89 | 23.46 | 7.82 |
Middle/deep zone assessment | 1.97 | 1.97 | ââ1.72 | 0.66 | ââ0.09 | 1.36 | 75.56 | 18.78 | 6.26 | 67.11 | 11.22 | 3.74 |
Matrix staining | 4.07** | 4.07 | ââ2.38* | 1.36 | 0.41 | 2.26 | 79.67 | 11.05 | 3.68 | 70.44 | 6.89 | 2.30 |
Overall assessment | 2.59* | 2.59 | ââ1.96* | 0.86 | 0.07 | 1.62 | 81.00 | 12.63 | 4.21 | 71.33 | 6.78 | 2.26 |
Overall rating | 3.388** | 6.606 | ââ2.310* | 1.129 | 0.259 | 1.959 | 76.55 | 9.83 | 328 | 66.91 | 6.76 | 2.25 |